首页> 外文期刊>Ophthalmic Surgery and Lasers >Intraocular pressure control and visual outcome in patients with phacolytic glaucoma managed by extracapsular cataract extraction with or without posterior chamber intraocular lens implantation.
【24h】

Intraocular pressure control and visual outcome in patients with phacolytic glaucoma managed by extracapsular cataract extraction with or without posterior chamber intraocular lens implantation.

机译:晶状体溶解性青光眼患者的囊内白内障摘除术伴或不伴后房人工晶状体植入术,其眼压控制和视觉效果。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND OBJECTIVE: To evaluate long-term intraocular pressure (IOP) control and visual outcome of patients with phacolytic glaucoma. PATIENTS AND METHODS: Forty-five consecutive eyes of 45 patients with phacolytic glaucoma operated on between January 1990 and December 1995 and who had completed at least 1 year of follow-up were included in the study. Of the 45 eyes, 17 eyes underwent extracapsular cataract extraction (ECCE) with primary posterior chamber intraocular lens (PC IOL) implantation (group 1). The rest of the eyes (n = 28) underwent only ECCE (group 2) in view of satisfactory aphakic vision in the contralateral eye. Preoperative IOP, visual acuity, and anterior segment appearance were compared with postoperative data. RESULTS: IOP was controlled (IOP < 21 mm Hg) in all of the patients without any antiglaucoma medication, with a mean follow-up of 29.11 +/- 16.25 months (range 12 to 60) and 43.2 +/- 21.5 (12 to 78) months in groups 1 and 2, respectively. The IOP remained controlled without antiglaucoma medication even in the patients where the desired visual recovery was not obtained due to glaucomatous disc damage because of delayed presentation (2 to 3 weeks or more). A visual acuity of 20/40 or better was achieved in 76.5% and 60.7% in groups 1 and 2, respectively. Eighteen of the 45 patients initially presented with light perception without projection. Eight of these 18 patients (44%) regained a visual acuity of 20/40 or better. There was no significant intraoperative and postoperative complication in any patient. CONCLUSIONS: ECCE with or without primary PC IOL implantation is safe and curative in patients with phacolytic glaucoma. The addition of trabeculectomy to cataract extraction seems to be superfluous in the control of IOP in patients with phacolytic glaucoma operated on within 2 to 3 weeks of the onset of symptoms. Light perception without projection is not a contraindication for cataract surgery in phacolytic glaucoma.
机译:背景与目的:评价长期晶状体溶解性青光眼患者的眼内压控制和视觉效果。患者与方法:1990年1月至1995年12月间手术且至少完成了1年随访的45例溶菌性青光眼患者的45只连续眼睛被纳入研究。在45眼中,有17眼接受了原发后房型人工晶状体(PC IOL)植入的白内障囊外摘除术(ECCE)(第1组)。鉴于对侧眼的无晶状体视力令人满意,其余的眼睛(n = 28)仅接受了ECCE(第2组)。将术前眼压,视力和前节外观与术后数据进行比较。结果:所有未使用任何抗青光眼药物的患者,IOP均得到控制(IOP <21 mm Hg),平均随访时间为29.11 +/- 16.25个月(12至60个月)和43.2 +/- 21.5(12至12个月)。第1组和第2组分别为78)个月。即使在由于延迟出现(2-3周或更长时间)而导致青光眼性椎间盘损伤而无法获得理想的视觉恢复的患者中,即使没有抗青光眼药物治疗,IOP仍可得到控制。第1组和第2组的视力分别为76.5%和60.7%,达到20/40或更高。 45例患者中有18例最初表现出无投射的光感。这18名患者中有8名(44%)的视力恢复了20/40或更高。任何患者均无明显的术中和术后并发症。结论:无论是否患有原发性PC IOL植入术,ECCE均可用于溶眼性青光眼患者。对于在症状发作后2至3周内手术的溶囊性青光眼患者,在白内障摘除术中加入小梁切除术似乎是多余的。没有投射的光线感知不是溶菌性青光眼白内障手术的禁忌症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号